Company: Oruka Therapeutics, Inc.

Form Type: 8-K

Filing Date: 2024-09-05

Corporate Action: Spin-off

Type: New

Accession Number: 000121390024076184

Comments: The document is not about a spin-off but rather a merger and reorganization involving Oruka Therapeutics, Inc. and ARCA biopharma, Inc.

Document Link: View Document